Also trades as: SNBIF (OTC) · $vol 0M
4592.T JPX
SanBio Company Limited
1W: -1.1%
1M: -3.0%
3M: -5.7%
YTD: -52.2%
1Y: -64.5%
3Y: +57.1%
5Y: -34.2%
¥944.00 ($5.98)
+3.00 (+0.32%)
Weekly Expected Move ±6.5%
¥819
¥880
¥941
¥1002
¥1063
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$3.8B
-5.2% ▼
Capital Expenditures
$33M
-570.6% ▼
5Y CAGR: -25.1%
Free Cash Flow
-$3.8B
-6.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$12.2B
+893.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4.6B | -$4.7B | -$2.5B | -$2.9B | -$3.8B |
| Depreciation & Amort. | $132M | $25M | $15M | $9M | $8M |
| Stock-Based Comp. | $141M | $103M | $0 | $19K | $0 |
| Change in Working Capital | $36M | $469M | -$445M | -$91M | -$132M |
| Other Non-Cash Items | $14M | $160M | -$1.8B | -$652M | $162M |
| Operating Cash Flow | -$6.5B | -$7.4B | -$4.8B | -$3.6B | -$3.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$56M | -$8M | -$11M | -$5M | -$33M |
| Acquisitions (Net) | $0 | $1M | $0 | $864K | $2M |
| Investment Purchases | $0 | $0 | $0 | $0 | -$400M |
| Investment Sales | $0 | $0 | $0 | $0 | $200M |
| Other Investing | -$10M | -$4M | -$8M | -$240K | -$19K |
| Investing Cash Flow | -$66M | -$10M | -$19M | -$4M | -$231M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.5B | -$1.6B | -$268M | -$268M | -$268M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$24M | $81M | -$35K | -$195K | -$36K |
| Financing Cash Flow | -$1.5B | $9.4B | $2.4B | $2.1B | $16.0B |
| Net Change in Cash | -$7.9B | $2.1B | -$2.3B | -$1.5B | $12.2B |
| Cash End of Period | $4.6B | $6.7B | $4.4B | $2.9B | $15.1B |
| Free Cash Flow | -$6.6B | -$7.4B | -$4.8B | -$3.6B | -$3.8B |